<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
   xmlns:content="http://purl.org/rss/1.0/modules/content/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:atom="http://www.w3.org/2005/Atom"
   xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
   xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
   xmlns:company="http://purl.org/rss/1.0/modules/company"
>
	<channel>
		<title>Latest News - Market Wire News</title>
		<atom:link href="https://marketwirenews.com/rss/news-releases/?s=cntb" rel="self" type="application/rss+xml" />
		<link>https://marketwirenews.com</link>
		<description>Market Wire News RSS News Feed for Connect Biopharma Holdings Limited (NASDAQ: CNTB)</description>
		<lastBuildDate>Thu, 16 Apr 2026 07:47:49 -0400</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod> hourly </sy:updatePeriod>
		<sy:updateFrequency> 60 </sy:updateFrequency>

		<image>
			<url>https://marketwirenews.com/assets/img/icons/favicon-32x32.png</url>
			<title>Market Wire News</title>
			<link>https://marketwirenews.com</link>
			<width>32</width>
			<height>32</height>
		</image>
		<item>
            <title>Market Wire News Hottest Alerts Newsletter</title>
            <link>https://marketwirenews.com/newsletter/</link>
            <pubDate>Thu, 16 Apr 2026 07:47:49 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Stock Picks]]></category>
            <category><![CDATA[Stock ALerts]]></category>
            <description><![CDATA[Subscribe to Market Wire News newsletter for instant real-time stock alerts, breaking financial news, trending stocks, and portfolio updates delivered to your email & mobile.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/newsletter/?v=2973</guid>
          </item>
          <item>
            <title>Market Wire News Trending Stocks</title>
            <link>https://marketwirenews.com/trending-stocks/</link>
            <pubDate>Thu, 16 Apr 2026 07:47:49 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Stock Picks]]></category>
            <category><![CDATA[Stock ALerts]]></category>
            <description><![CDATA[Track today's hottest trending stocks on NASDAQ, NYSE, OTCMKTS & Canadian markets. See massive % gainers, real-time movers, volumes, and linked breaking news updates.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/trending-stocks/?v=2973</guid>
          </item>
          <item>
            <title>Market Wire News Investor Awarenewss</title>
            <link>https://marketwirenews.com/advertise/</link>
            <pubDate>Thu, 16 Apr 2026 07:47:49 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Invesor Awareness]]></category>
            <category><![CDATA[Investor Releatios]]></category>
            <description><![CDATA[Stock Promoter, Investor Relations, Investor Awareness, Market Wire News, investor brand advertisement services, plans and pricing.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/advertise/?v=2973</guid>
          </item>
		<item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews March 31, 2026 04:05:00 pm</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-reports-2025-full-year-financial-r-6807680736659530.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 31 Mar 2026 16:05:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD &#x2013;      &#x2013; Results from Phase 3 study of rademikibart in moderate-to-severe AD presented in late-breaking research session at AAD &#x2013;      &#x2013; Recruitment ongoing fo...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-reports-2025-full-year-financial-r-6807680736659530.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews March 30, 2026 07:02:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-20-2-million-private-pla-5794148765801387.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 30 Mar 2026 07:02:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[Funding from new and existing investors extends anticipated cash runway into the second half of 2027    SAN DIEGO, March 30, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma,&#x201D; &#x201C;Connect&#x201D; or the &#x201C;Company&#x201D;), a cl...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-20-2-million-private-pla-5794148765801387.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews March 30, 2026 07:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-positive-topline-data-fr-8135148141951770.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 30 Mar 2026 07:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Rademikibart administered as a single 300 mg 2-minute IV push to asthma and chronic obstructive pulmonary disease&#xA0; ( COPD) patients produced rapid improvement in FEV   1    with many patients experiencing improvements in airway function of &#x2265;200 mL as early as 15 minutes post-...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-positive-topline-data-fr-8135148141951770.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews March 10, 2026 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/results-from-phase-3-study-of-rademikibart-in-modera-5796457527462024.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 10 Mar 2026 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect, or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that the results of a P...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/results-from-phase-3-study-of-rademikibart-in-modera-5796457527462024.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews March 03, 2026 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-the-leerink-partners-6161084087487264.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 03 Mar 2026 09:00:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D;, &#x201C;Connect&#x201D;, or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory d...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-the-leerink-partners-6161084087487264.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews February 19, 2026 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-the-oppenheimer-36th-6037772760376260.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 19 Feb 2026 09:00:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D;, &#x201C;Connect&#x201D;, or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory di...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-the-oppenheimer-36th-6037772760376260.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews January 12, 2026 08:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-highlights-new-mechanism-of-action-7056550683341078.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 12 Jan 2026 08:00:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Announced new data demonstrating a unique mechanism of action supporting the best-in-class potential of rademikibart &#x2013;     &#x2013; Recruitment ongoing for Phase 1b study of intravenously-administered rademikibart designed to further confirm its unique ability to rapidly improve a...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-highlights-new-mechanism-of-action-7056550683341078.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews November 24, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-the-8th-annual-everc-8683840363553892.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 24 Nov 2025 09:00:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D;, &#x201C;Connect&#x201D;, or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory di...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-the-8th-annual-everc-8683840363553892.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews November 12, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-reports-third-quarter-2025-financi-4585540400677516.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 12 Nov 2025 09:00:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Recruitment ongoing for Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD; expect to report topline data from both studies in 1H26 &#x2013;         &#x2013; New Drug Application for rademikibart for the treatment of atopic dermatitis submitted by Simcere, the Comp...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-reports-third-quarter-2025-financi-4585540400677516.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews September 29, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-presents-data-supporting-rademikib-6653246197826432.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 29 Sep 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Rademikibart demonstrated rapid and significant improvement in lung function and asthma control in patients, with greatest improvements observed in those with elevated baseline levels of key type 2 inflammatory markers &#x2013;         &#x2013; Significant reduction in annualized exacerb...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-presents-data-supporting-rademikib-6653246197826432.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews September 04, 2025 08:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-two-presentations-at-the-6043408947693944.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 04 Sep 2025 08:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced two poster presentations...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-two-presentations-at-the-6043408947693944.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews September 03, 2025 08:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-completes-termination-of-its-ameri-8745162092620282.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 03 Sep 2025 08:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D; or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced t...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-completes-termination-of-its-ameri-8745162092620282.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews August 27, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-two-upcoming-investo-6669436810831354.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 27 Aug 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that Company management w...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-two-upcoming-investo-6669436810831354.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews August 14, 2025 08:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-teams-with-ickey-woods-and-the-jov-7755974935799924.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 14 Aug 2025 08:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[Company and Former Cincinnati Bengals Running Back Known for the &#x201C;Ickey Shuffle&#x201D; Collaborate to Raise Awareness and Drive Asthma Education with Focus on Acute Attacks       SAN DIEGO and CINCINNATI, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-teams-with-ickey-woods-and-the-jov-7755974935799924.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews August 13, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-reports-second-quarter-2025-financ-8095036673585247.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 13 Aug 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Initiated Phase 2 Seabreeze STAT asthma and COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations &#x2013;         &#x2013; Presented positive data at ATS 2025 and EAACI 2025 supporting the potential of rademikibart to deliver differentiated efficacy and sa...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-reports-second-quarter-2025-financ-8095036673585247.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews July 22, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-appoints-industry-veteran-jim-scho-7295533383503136.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 22 Jul 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Mr. Schoeneck is a seasoned industry executive and director with deep expertise in development and commercialization of breakthrough products and guiding companies through significant transformation and growth &#x2013;       SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-appoints-industry-veteran-jim-scho-7295533383503136.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews July 21, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-plans-to-terminate-its-a-8729831850140921.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 21 Jul 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D; or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced th...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-plans-to-terminate-its-a-8729831850140921.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews July 18, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-participate-in-the-btig-virtual-7686518419106643.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 18 Jul 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D;, &#x201C;Connect&#x201D;, or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory di...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-participate-in-the-btig-virtual-7686518419106643.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews July 17, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-regains-compliance-with-nasdaq-min-4719691480583313.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 17 Jul 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D; or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced it...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-regains-compliance-with-nasdaq-min-4719691480583313.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews July 09, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-s-exclusive-licensee-in-china-simc-5190180506044498.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 09 Jul 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D;, &#x201C;Connect&#x201D;, or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory di...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-s-exclusive-licensee-in-china-simc-5190180506044498.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews June 13, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-presents-data-supporting-rademikib-6976532849795988.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 13 Jun 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma &#x2013;         &#x2013; Rademikibart reduced annualized exacerbations in patients with eosinophilic-driven type 2 asthma &#x2013;         &#x2013; Data supports ongoi...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-presents-data-supporting-rademikib-6976532849795988.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews June 03, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-two-oral-presentations-a-4589856435617448.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 03 Jun 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D; or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic obstructive pulmonary ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-two-oral-presentations-a-4589856435617448.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews May 28, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-two-upcoming-investo-4945090830950226.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 28 May 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D; or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic obstructive pulmonary d...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-two-upcoming-investo-4945090830950226.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews May 20, 2025 09:00:21 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-presents-data-supporting-developme-7097220576961179.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 20 May 2025 09:00:21 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Rademikibart significantly improved airway function, as measured by FEV       1       , within a day and significantly reduced acute exacerbations in patients with inflammation-mediated chronic asthma strongly supporting ongoing Phase 2 acute exacerbation studies in asthma and COPD which...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-presents-data-supporting-developme-7097220576961179.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews May 15, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-reports-first-quarter-2025-financi-6455678646095911.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 15 May 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[Initiated Phase 2 Seabreeze STAT Asthma and Seabreeze STAT COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations in Asthma and COPD in May 2025; topline data expected in 1H 2026         Published positive data from its global Phase 2 study supporting potential of ra...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-reports-first-quarter-2025-financi-6455678646095911.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews May 14, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-initiates-phase-2-seabreeze-stat-c-6490350406813583.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 14 May 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 &#x2013;       SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on tran...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-initiates-phase-2-seabreeze-stat-c-6490350406813583.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews May 13, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-initiates-phase-2-seabreeze-stat-a-7899405609193348.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 13 May 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Expect to report topline data from the Seabreeze STAT Asthma study in 1H 2026 &#x2013;         &#x2013; On track to initiate similarly-designed Phase 2 study in patients with COPD imminently &#x2013;       SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Na...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-initiates-phase-2-seabreeze-stat-a-7899405609193348.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews April 24, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-multiple-presentations-a-5068594218888349.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 24 Apr 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Data to be presented supports development of rademikibart for patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation &#x2013;         &#x2013; Advancing rapid clinical development plan for rademikibart; expect to initiate parallel Phase 2 trials in 2Q25 &#x201...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-multiple-presentations-a-5068594218888349.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews April 01, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-positive-type-c-meeting--7076008889675697.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 01 Apr 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation &#x2013;         &#x2013;&#xA0;Expect to initiate both trials in Q2 2025 &#x2013;       SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE)...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-positive-type-c-meeting--7076008889675697.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews March 31, 2025 04:05:00 pm</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-publication-of-positive--5898253844109859.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 31 Mar 2025 16:05:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[&#x2013; Rademikibart demonstrated rapid onset of action with significant improvements in lung function observed at one week and maintained through 24 weeks &#x2013;         &#x2013; In patients with eosinophilic-driven asthma (&#x2265;300 eosinophils/&#xB5;L) receiving rademikibart for     24 we...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-publication-of-positive--5898253844109859.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews March 31, 2025 09:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-reports-2024-full-year-financial-r-8915740911616221.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 31 Mar 2025 09:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[Strengthened leadership team with key appointments, including Barry Quart, Pharm.D. as CEO, and David Szekeres as President, bringing deep clinical, regulatory, operational and strategic expertise         Unveiled rapid clinical development program for rademikibart initially targeting acute care ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-reports-2024-full-year-financial-r-8915740911616221.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews March 28, 2025 04:05:00 pm</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-receipt-of-nasdaq-defici-5700055210582800.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 28 Mar 2025 16:05:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD), today announced...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-announces-receipt-of-nasdaq-defici-5700055210582800.html?s=cntb?v=<?php echo 2973;?></guid>
            </item><item>
            <title>$CNTB Connect Biopharma Holdings Limited #MWN #BreakingNews March 03, 2025 08:00:00 am</title>
            <link>https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-two-upcoming-investo-7092203823913384.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 03 Mar 2025 08:00:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CNTB]]></category>
            <category><![CDATA[Connect Biopharma Holdings Limited]]></category>
            <description><![CDATA[SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (&#x201C;Connect Biopharma&#x201D; or the &#x201C;Company&#x201D;), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care in Asthma and Chronic Obstructive Pulmonary...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/cntb/news/connect-biopharma-to-present-at-two-upcoming-investo-7092203823913384.html?s=cntb?v=<?php echo 2973;?></guid>
            </item>
	</channel>
</rss>